Literature DB >> 10966821

Conformational changes in serpins: II. The mechanism of activation of antithrombin by heparin.

J C Whisstock1, R N Pike, L Jin, R Skinner, X Y Pei, R W Carrell, A M Lesk.   

Abstract

Antithrombin, uniquely among plasma serpins acting as proteinase inhibitors in the control of the blood coagulation cascade, circulates in a relatively inactive form. Its activation by heparin, and specifically by a pentasaccharide core of heparin, has been shown to involve release of the peptide loop containing the reactive centre from partial insertion in the A sheet of the molecule. Here we compare the structures of the circulating inactive form of antithrombin with the activated structure in complex with heparin pentasaccharide. We show that the rearrangement of the reactive centre loop that occurs upon activation is part of a widespread conformational change involving a realignment of the two major domains of the molecule. We also examine natural mutants that possess high affinity for heparin pentasaccharide, and relate the kinetics of their interaction with heparin pentasaccharide to the structural transitions occuring in the activation process. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10966821     DOI: 10.1006/jmbi.2000.3982

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  22 in total

1.  Structural and functional characterization of a highly specific serpin in the insect innate immunity.

Authors:  Sun Hee Park; Rui Jiang; Shunfu Piao; Bing Zhang; Eun-Hye Kim; Hyun-Mi Kwon; Xiao Ling Jin; Bok Luel Lee; Nam-Chul Ha
Journal:  J Biol Chem       Date:  2010-11-03       Impact factor: 5.157

2.  Effects of sulfate position on heparin octasaccharide binding to CCL2 examined by tandem mass spectrometry.

Authors:  Matt D Sweeney; Yonghao Yu; Julie A Leary
Journal:  J Am Soc Mass Spectrom       Date:  2006-06-02       Impact factor: 3.109

3.  Antithrombin-binding oligosaccharides: structural diversities in a unique function?

Authors:  Marco Guerrini; Pierre A J Mourier; Giangiacomo Torri; Christian Viskov
Journal:  Glycoconj J       Date:  2014-10       Impact factor: 2.916

Review 4.  Molecular mechanisms of antithrombin-heparin regulation of blood clotting proteinases. A paradigm for understanding proteinase regulation by serpin family protein proteinase inhibitors.

Authors:  Steven T Olson; Benjamin Richard; Gonzalo Izaguirre; Sophia Schedin-Weiss; Peter G W Gettins
Journal:  Biochimie       Date:  2010-06-02       Impact factor: 4.079

5.  Conformational activation of antithrombin by heparin involves an altered exosite interaction with protease.

Authors:  Gonzalo Izaguirre; Sonia Aguila; Lixin Qi; Richard Swanson; Ryan Roth; Alireza R Rezaie; Peter G W Gettins; Steven T Olson
Journal:  J Biol Chem       Date:  2014-10-20       Impact factor: 5.157

6.  Peptidomic Analysis of Rat Plasma: Proteolysis in Hemorrhagic Shock.

Authors:  Federico Aletti; Elisa Maffioli; Armando Negri; Marco H Santamaria; Frank A DeLano; Erik B Kistler; Geert W Schmid-Schönbein; Gabriella Tedeschi
Journal:  Shock       Date:  2016-05       Impact factor: 3.454

7.  A computational modeling and molecular dynamics study of the Michaelis complex of human protein Z-dependent protease inhibitor (ZPI) and factor Xa (FXa).

Authors:  Vasudevan Chandrasekaran; Chang Jun Lee; Ping Lin; Robert E Duke; Lee G Pedersen
Journal:  J Mol Model       Date:  2009-01-27       Impact factor: 1.810

8.  Molecular basis of factor IXa recognition by heparin-activated antithrombin revealed by a 1.7-A structure of the ternary complex.

Authors:  Daniel J D Johnson; Jonathan Langdown; James A Huntington
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-22       Impact factor: 11.205

Review 9.  Exosite determinants of serpin specificity.

Authors:  Peter G W Gettins; Steven T Olson
Journal:  J Biol Chem       Date:  2009-04-28       Impact factor: 5.157

10.  The critical role of hinge-region expulsion in the induced-fit heparin binding mechanism of antithrombin.

Authors:  Jonathan Langdown; Klara J Belzar; Wendy J Savory; Trevor P Baglin; James A Huntington
Journal:  J Mol Biol       Date:  2009-03-13       Impact factor: 5.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.